Titan Pharmaceuticals, Inc.

Navigate Titan Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Who We Are
    • IP Portfolio
    • Management Team
    • Board of Directors
    • Careers
  • Technology
  • Pipeline
    • Kappa Opioid Receptor Agonist
    • Nalmefene Implant
  • News
    • Overview
    • Press Releases
    • Events
    • Presentations
    • In the News
    • Publications
    • Posters
    • Media Resources
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • Search
  • Twitter

Press Releases

  • Home
  • Investors
  • News / Events
  • Press Releases
Investors

Navigate Investors

  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Press Releases

  • All News
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009

Titan Pharmaceuticals Adopts Stockholder Rights Plan, Files Shelf Registration of Securities on Form S-3

December 21, 2011

Titan Pharmaceuticals Confirms Regulatory Guidance for Probuphine

December 1, 2011

Titan Pharmaceuticals Announces Probuphine Presentation at American Society of Addiction Medicine Conference

October 20, 2011

Titan Pharmaceuticals Announces Second Quarter 2011 Financial Results

August 16, 2011

Titan Pharmaceuticals Provides Additional Positive Results in Confirmatory Phase 3 Trial of Probuphine

August 16, 2011

Titan Pharmaceuticals Schedules Conference Call to Review Second Quarter 2011 Financial Results and Probuphine Phase 3 Clinical Study Results

August 9, 2011

Titan Pharmaceuticals Announces Positive Top Line Results in Confirmatory Phase 3 Trial of Probuphine

July 11, 2011

Titan Pharmaceuticals Provides Update on Confirmatory Phase 3 Study of Probuphine

June 30, 2011

Titan Pharmaceuticals to Present at 2011 BIO International Convention

June 27, 2011

Titan Pharmaceuticals Provides Additional Details on Confirmatory Phase 3 Study of Probuphine

June 17, 2011

RSS
  • 1
  • 2
  • Next »
© 2023 Titan Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Titan FCOI Policy Disclaimer Sitemap Twitter